Advent Pharmaceuticals Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$12.5M
Advent Pharmaceuticals General Information
Description
Operator of a drug development company intended to offer global respiratory products. The company's services mainly focus on developing inhaled drug products for the treatment of asthma and other pulmonary diseases, enabling caregivers to facilitate the treatment for respiratory problems.
Contact Information
Website
www.advent-pharma.comCorporate Office
- Post Office Box 556
- Mount Waverley, Victoria 3149
- Australia
Corporate Office
- Post Office Box 556
- Mount Waverley, Victoria 3149
- Australia
Advent Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Dec-2018 | $12.5M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 15-Jul-2005 | Completed | Startup |
Advent Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Advent Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| QIC BioVentures | Venture Capital | Minority | ||
| Talu Ventures | Venture Capital | Minority |
Advent Pharmaceuticals FAQs
-
When was Advent Pharmaceuticals founded?
Advent Pharmaceuticals was founded in 2001.
-
Where is Advent Pharmaceuticals headquartered?
Advent Pharmaceuticals is headquartered in Mount Waverley, Australia.
-
What industry is Advent Pharmaceuticals in?
Advent Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Advent Pharmaceuticals a private or public company?
Advent Pharmaceuticals is a Private company.
-
What is the current valuation of Advent Pharmaceuticals?
The current valuation of Advent Pharmaceuticals is .
-
What is Advent Pharmaceuticals’s current revenue?
The current revenue for Advent Pharmaceuticals is .
-
Who are Advent Pharmaceuticals’s investors?
QIC BioVentures and Talu Ventures have invested in Advent Pharmaceuticals.
-
When was Advent Pharmaceuticals acquired?
Advent Pharmaceuticals was acquired on 01-Dec-2018.
-
Who acquired Advent Pharmaceuticals?
Advent Pharmaceuticals was acquired by Aurobindo Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
